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1. Introduction
Since the discovery of Electron Paramagnetic Resonance (EPR) spectroscopy in 1944 by Za‐
voisky[1], and the realization of the Nuclear Magnetic Resonance (NMR) spectroscopic sig‐
nal in the mid 1940’s by Bloch and Purcell[2,3], the capabilities and applications of the
technology have continued to advance at an enormous rate particularly after the implemen‐
tation of Fourier transform NMR in the mid 1960’s by Ernst[4]. Magnetic Resonance (MR)
spectroscopy was initially utilized to characterize the structure of matter.[1,5] Through the
early to mid 1970’s, the development of multidimensional (nD) methods and more powerful
instruments opened the door for the detailed atomistic characterization of small molecules
culminating in structural elucidation of proteins by the mid 1980’s.[6] At about the same
time, it was proposed that a magnetic field gradient could be applied to obtain a 3-dimen‐
sional (3D) image leading to the invention of nuclear Magnetic Resonance Imaging (MRI)
with, among other capabilities, the potential to monitor the bio-distribution and bio-accu‐
mulation of molecules in vivo.[7] Beyond the 1980’s MR technologies were mixing with other
technologies and evolving to play an integral role for advancing pharmaceuticals and be‐
coming indispensable tools for drug discovery, design and diagnostics.
1.1. Capabilities
Early on it was recognized (see Ref. 8 and references therein) that MR techniques can offer a
variety of unique advantages over other spectroscopic techniques such as MR is completely
non-destructive and non-invasive. Thus, MR technologies can be utilized with inanimate
samples or living organisms with no obvious detrimental or destructive effects. In addition,
MR techniques can be applied to a variety of states of matter including solution, semi-solids,
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solids and mixtures obtaining comprehensive information of the chemical and physical
properties. In addition to the typical static structural information, one can also detail dy‐
namic processes. NMR measurements provide information about dynamic processes with
rates in the range from 10-2 to 10-10 sec-1. Furthermore, many nuclei possess magnetic mo‐
ments, and with the availability of more sensitive spectrometers, chemists are beginning to
take greater advantage of the technique for structure/bonding information for organometal‐
lic compounds (for example see Ref. 9).
An important application, although commonly overlooked, is the accurate quantitative in‐
formation that can be obtained without the need for laborious calibrations. Under quantita‐
tive conditions and for all practical purposes with semi-solid or solution state samples,
NMR spectroscopy has the unique distinction of having a uniform molar response for all
nuclei of the same type i.e. all 1H nuclei have the same integrated intensity and thus, a single
calibrated (internal or more significantly external) standard can be used for accurate quanti‐
tation.[10] For the aforementioned reasons NMR is a valuable tool for providing atomistic
structural, dynamic and quantitative information on natural products such as small mole‐
cules, metabolites, peptides, proteins, complex mixtures, and molecular assemblies such as
lipid bilayers or tissues.
Nuclear MRI, on-the-other-hand, can provide 3D images of macroscopic matter, and moni‐
tor the bio-accumulation and bio-distribution of MRI tagged natural products in vivo. Ulti‐
mately MR technologies can be used at almost every stage along the natural product
discovery pipeline – from discovery to implementation, from molecules to medicine.
1.2. Scope and limitations
MR technologies encompass a range of techniques including electron or nuclear MR spectro‐
scopy, MR time domain, and nuclear or electron MRI. Herein, this chapter focuses on the
nuclear MR technologies of spectroscopy and imaging for solution and semi-solid states. We
provide a general overview of techniques and methodologies applicable throughout the de‐
velopment pipeline for natural products, as well as some potential impacts the information
has for product development. It is well beyond the scope of a chapter (or in fact an entire
book) to be a comprehensive description of all applicable MR methodologies. Thus within
each section, the reader is directed to review articles, books, etc.
2. NMR spectroscopy
NMR is a technique that detects electrical currents induced by precessing nuclear magnetic
moments within a uniform static magnetic field.[11] Nuclei with non-zero spin moments are
MR active and in principle are detectable. Each individual type of spin-active nucleus has a
unique precessional frequency dependent upon the strength of the static magnetic field, the
magnetic properties of the isotope and the local electronic environment of the nucleus. The
general precessional frequency is dependent upon the type of nucleus and thus NMR can
readily distinguish among for example 13C, 1H, 2H or 3H. The applications and significance
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of NMR has exploded because the exact precessional frequency (i.e. the chemical shift) with‐
in a group of the same nuclei is influenced by the local electronic environment of the nuclei
and thus, NMR can readily distinguish (for example) a 1H nuclei that is chemically bound to
different nuclei (e.g. carbon vs. nitrogen, etc.), is chemically bound to different oxidation
states of the same nuclei (e.g. methyl vs. methylene carbon), and/or are in identical bonding
environments (e.g. methyl 1H nuclei) but in different electronic environments induced by
surrounding functional groups (e.g. aromatic vs. carbonyl groups). In addition, if a nucleus
is influenced by another spin active nucleus either through a bond connection or in spatial
proximity, a correlation exists that may be NMR detectable. In this way atomistic properties
(such as the 3D spatial arrangement of nuclei and dynamics) can be determined.[12]
In addition to the distinct nuclear chemical shift, data from MR can be further separated
based upon relaxation and/or diffusion properties of a nucleus or molecule.[12,13] Thus, MR
technologies can discriminate among large molecules like peptides, proteins and macromo‐
lecular assemblies, and small molecules like metabolites or synthetic organic molecules. The
relaxation time (influenced by the rotational correlation time and molecular fluctuations) of
a molecule plays an important role in distinguishing among small drug molecules and large
proteins, or between a single lipid molecule that behaves as a small molecule and an assem‐
bly of lipid molecules that, as a collective, behave as large molecules.
One drawback is that under typical conditions MR techniques are sample intensive requir‐
ing µM to mM concentrations translating to µg to g quantities of material. For natural prod‐
uct discovery, the sample intensive requirement can be an issue as extracts may only contain
nano to micro gram quantities of material.[14] A number of methods have been proposed to
overcome the mass demand with the most significant for general applications being the in‐
vention of cryogenically helium cooled detection systems that substantially reduce thermal
noise ultimately improving the signal-to-noise ratio by up to 10 fold and reducing data ac‐
quisition times by up to 100 times.[15,16] A next generation improvement is cryogenically
cooled probes that require smaller sample volumes. Currently the combination of the 700
MHz NMR spectrometer and new detection technologies requiring only 35 µl of sample af‐
fords the Biomolecular Magnetic Resonance Facility at NRC-Halifax one of the world’s most
sensitive instruments for mass-limited samples reducing the typical quantities by up to 50
times.[17] The limits of detection for this instrument can be as low as 10 nano-grams for
small molecules (IWB, NM, TK and RTS unpublished).
Although to some extent the sample intensive nature of NMR can be addressed, a second
drawback for larger proteins and macromolecular assemblies (>40 kDa) is the loss of peak
resolution due to spectral overlap, broad line-widths, reduced signal-to-noise ratios and in‐
creased spectral complexity[12]. There have been efforts to address this issue however, these
efforts are limited in scope and application.[18-20]
2.1. Structure elucidation
After a natural product or extract has been verified to be biologically active, an essential
component within the discovery pipeline is to identify compound(s) and determine struc‐
ture(s). Structural elucidation is essential if chemical modifications are to be made, if the
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product is for human consumption and/or if a patent application is to be filed as it will dis‐
tinguish the uniqueness of the compound as well as help identify relationships with pre-ex‐
isting compounds. Structural characterization is somewhat different between small and
large molecules; the distinction between the two regimes is defined by the Nuclear Over‐
hauser Effect (nOe) cross-relaxation rate which is positive or negative depending upon the
spectrometer frequency and the overall molecular tumbling time.[12] Generally, “small mol‐
ecules” are regarded as molecules that do not aggregate and have a molecular mass of <1
000 atomic mass units.
2.1.1. Small molecules
The advent of nD experiments propelled NMR to be a leading tool for natural product char‐
acterization. Previously natural products were degraded into fragments, chemically derivat‐
ized and/or completely synthesised to confirm the structure. It is still valuable for structure
elucidation using NMR to obtain information from the aforementioned techniques as well as
other techniques such as mass spectrometry (MS; for exact mass, functional groups and con‐
nectivities), infra-red spectroscopy (for functional groups), and separation techniques (for
classes of compound e.g. phenolic, steroid, protein, etc.).
The initial NMR spectroscopic assessment as outlined in Scheme 1, typically begins with 1-
dimensional (1D) 1H spectra to determine purity, confirm the compound class, and examine
the general appearance of the peaks. A spectrum with sharp well resolved peaks and the an‐
ticipated ratio of integrated intensities is indicative of a pure sample dissolved in an appro‐
priate solvent. Broad peaks or peaks that are of fractional ratio could indicate an impure
sample, however, they could also be an indication of chemical exchange or limited solubili‐
ty. The preliminary information gained from other techniques is important when ascertain‐
ing if the spectral appearance is appropriate. From 1D data the splitting patterns from J-(i.e.
scalar)-couplings provide information on the pattern of covalent bonding as well as the tor‐
sional angle distributions between spin active nuclei 3-bonds apart.[21]
1H detected 2-dimensional (2D) experiments in which magnetic coherence is propagated
through J-couplings or magnetization is transferred through dipole-dipole cross-relaxation
interactions, reduce the overlap complexity of 1D spectra and provide correlations to other
1H nuclei or heteronuclei most commonly 13C or 15N. Common homonuclear 1H-1H 2D ex‐
periments based on J-couplings are TOtal Correlation SpectroscopY (TOCSY)[22], and COr‐
relation SpectroscopY (COSY)[23]. Both of these experiments provide information on
individual spin systems and chemical bonding. COSY experiments are used to connect 1H
nuclei that are within 3-bonds of each other whereas TOCSY experiments can connect all
spins belonging to a J-coupled network e.g. the entire spin system connected through 3-bond
correlations. Analysis of COSY data can provide J-coupling constants which can be related
via the Karplus curve[24] to torsional angle restraints.[21]
Homonuclear 2D 1H-1H nOe SpectroscopY (NOESY)[25] and Rotating frame Overhauser Ef‐
fect SpectroscopY (ROESY)[26] experiments are based on dipolar cross-relaxation interac‐
tions providing distance information between nuclei that are physically close (up to ≈5 Å) in
space. It is noteworthy to mention that for NOESY and ROESY spectra to have correlations,
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nuclei do not have to be on the same molecule. This aspect of the nOe provides the basis for
determining ligand/receptor interaction characteristics (see Section 2.2). The sign and inten‐
sity of NOESY cross-peaks are dependent upon the main static magnetic field (ω0 = B0) and
the rotational correlation time of the molecule (τc); for small molecules (<1 kDa) the nOe
cross-relaxation rate is positive whereas for larger molecules (>2 kDa) the nOe is negative.
ROESY are best suited for medium size molecules of ~1 kDa where for NOESY the nOe be‐
comes zero (i.e. ω0τc ≈ 1.12)[26]. Analysis of the NOESY and/or ROESY data is important for
determining the configuration/conformation of the compound and for connecting individual
spin systems determined from the TOCSY and/or COSY data. Another aspect of nD NMR
techniques is the addition of 13C editing to the spectra. These heteronuclear experiments are
1H detected increasing the sensitivity and indirectly providing 13C shifts especially impor‐
tant for mass limited samples. Standard heteronuclear experiments are 1H-13C-HSQC[27-29],
1H-13C-HMBC[30], and 1H-13C-H2BC[31]. Strategies for selecting the proper pulse sequences,
acquisition and processing parameters for natural product elucidation has been previously
reviewed.[32] Implementing higher-dimensional experiments, for example, HSQC-TOCSY,
HSQC-NOESY, provides valuable information for complex natural products on the through
bond or space connections by exploiting the heteronuclei chemical shift for further separa‐
tion.
When assessing the structure of a chemically modified molecule or a molecule for which mi‐
nor structural changes are suspected, acquiring a complete structural suite of experiments
may not be necessary. In such circumstances, a series of edited 1D and 2D experiments have
been developed that can isolate the chemical modification of interest and express only corre‐
lations to the modification. Isolating a particular peak of interest reduces the time required
for data acquisition, simplifies analysis and can help to quickly confirm modifications; val‐
uable tools for isolating information from complex molecules are reviewed in Ref. 33.
A standard approach for small molecule structure elucidation involves identification of the
individual fragments or spin systems followed by their assembly.[34] This approach out‐
lined in Scheme 1 uses 1D data to assess purity, classify the compound type and compare
with NMR chemical shift databases. Analysis of the 2D homonuclear data (COSY and TOC‐
SY) identifies the individual short spin systems in the compound. Heteronuclear HSQC data
provides 13C chemical shift information and direct H-C links. HMBC data links distant H-C
spin systems that help link molecular fragments. Data from the NOESY and ROESY spectra
also aid in linking spins systems, and determining relative configuration and conformation,
for example, relative stereochemistry, ring junctions, and double bond regiochemistry. The
final step is confirming that proposed shift assignments and structural characteristics agree
with coupling constants and splitting patterns among spectra, along with other data collect‐
ed. There are numerous books detailing the specifics for analyzing NMR data of small mole‐
cules, see for example Refs. 35-38.
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Scheme 1. The flowchart can be utilized as a general scheme for small natural product structural elucidation. Typical‐
ly, a series of 1H and 13C NMR experiments are required in order to fully confirm the structure.
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2.1.2. Proteins & peptides
MR allows for structural characterization of moderately sized proteins or peptides.[12,39]
Since the line width of the NMR signal depends upon the rotational correlation time τc, the
resultant signal intensity reduction and decreased spectral resolution typically precludes de‐
tailed analysis of large proteins. To date the largest protein to be structurally characterized
by NMR is the 82 kDa or 723 amino acid malate synthase G.[40] In contrast, X-ray techni‐
ques in principle have no size limit however, not all proteins are amenable to crystallization
esp. membrane-associated proteins and crystallization can alter the protein structure[41]
making NMR attractive for elucidating structures in “native” solution environments. “Non-
native” conditions can also be applicable for protein folding/unfolding or temperature sta‐
bility. Initial investigation into biomolecular structure elucidation typically requires
information from other techniques such as MS, circular dichroism, micro-array for initial de‐
termination of the amino acid sequence. A general scheme for the elucidation of a protein
3D structure (Scheme 2) involves initial production of the protein either by synthesis and re‐
folding, or by recombinant expression, and followed by acquisition and data analysis. From
the analysis through bond backbone and side-chain connections, through space nOe connec‐
tions and additional constraints are utilized as restraints within simulated annealing proto‐
cols that calculate superimposable ensembles of lowest-energy structures.[42]
NMR is a sample intensive technique requiring milligrams of the biomolecule. For small
peptides, synthesis (mg quantities) is typical and offers the possibility of selective isotopic
labelling with the preferred spin active nuclei 13C (over the 98% natural abundant spin-inac‐
tive 12C) and/or 15N (over the 99% natural abundance quadrupole and difficult to observe
14N). However for large proteins, synthesis is too onerous and costly. Therefore develop‐
ment of a recombinant expression protocol capable of producing bacterial, mammalian or
other proteins with the correct folding and linkages (in the case of lipoproteins or polysac‐
charide proteins) is required. In addition, expression systems allow for point mutations. For
proteins >50 amino acids it is advantageous to label the protein with the isotopes 13C and
15N. Alternatively, structure elucidation of small monomeric peptides of <50 amino acids
does not necessarily require labelling and the experiments and strategies outlined in Section
2.1.1 can be utilized. Isotopically labelled proteins can be achieved by growing E. coli with
the particular expression gene on minimal media supplemented with 13C6-glucose and/or
15N ammonium chloride. Although E. coli is widely used for its low cost, the high productiv‐
ity yields depend upon the plasmid, host and tags.[43] In addition with prokaryotic systems,
protein re-folding can be a potential bottle neck along with failure to express toxic proteins,
degradation and the absence of post-modification. Other non-E. coli prokaryotic and eukary‐
otic cell-lines that have been used for labelling, such as insect cells[44], are reviewed in Ref.
45. Eukaroytic Pichia pastoris has been widely and successfully used for labelling using mini‐
mal media,[46] and cell-free expression allows for high yields with relatively small reaction
volumes[47]. With cell-free, any combination of labelled and unlabelled amino acids can be
incorporated into the protein without isotopic scrambling.[47] An advantage of the cell-free
system is that reagents, that stabilize expression, can be added. For example, protease inhibi‐
tors, detergents or membrane mimetics for insoluble or membrane associated proteins.[48]
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However, each amino acid is added to the medium which can become costly for uniform 15N
and/or 13C labelling. Overall, the particular expression system used depends upon such fac‐
tors as post-translational modifications, the labelling scheme, membrane association, total
cost and expression efficiency.
Over the past decade specialized isotope labelling strategies have been developed for bio‐
molecular NMR, including full or partial deuteration, specific amino acid labelling and re‐
giospecific labelling.[49] Labelling proteins with deuterium is practical for simplifying
complex NMR spectra or for studying protein-substrate complexes. Furthermore, as the mo‐
lecular weight of the biomolecule increases the spin-spin relaxation time (T2) decreases con‐
siderably, inhibiting coherence transfer along amino acid side-chains. Substitution of 2H for
1H nuclei increases T2 enhancing the coherence transfer. Perdeuteration of the backbone pre‐
vents connection to the side-chain 1H nuclei, whereas a random, uniform deuteration level
between 50% and 90% is most desirable. [50,51] Nevertheless, perdeuteration is beneficial
for studying protein-substrate or protein-protein complexes, in which one portion of the
complex is “invisible” reducing the overlap and spectral complexity allowing information of
conformational changes to be more readily identified. In the pursuit of NMR information of
larger proteins, labelling strategies have been developed for selective methyl labelling of ala‐
nine, leucine, valine and isoleucine (Hγ1) residues with perdeuteration of the backbone. This
labelling scheme allowed for the analysis of relaxation dynamics of a 1 MDa protein com‐
plex.[52,53] Site specific information on protein conformational changes upon substrate
binding can be obtained from selective amino acid labelling of the backbone. Within the pro‐
tocol, media is supplemented with isotopically labelled amino acids, isotopic scrambling
may result in instances where the supplemented amino acids are precursors to other amino
acids. Scrambling of the isotope labels can be overcome by using E. coli strains with lesions
in their biosynthetic pathways,[54] and recently demonstrated with a prototphic strain.[55]
Contrary to selective amino acid labelling it has been proposed that unlabelling specific ami‐
no acids against a uniformly 13C/15N labelled background is beneficial.[56] Selective unlabel‐
ling of the protein still allows for sequential assignment of regions of the protein. Segmental
labelling of individual domains or portions of large proteins has been established in which
labelled segments of the protein are ligated together.[57,58] Segmental labelling of a large
protein is useful for studying domain-domain interactions[59], conformational changes and
substrate binding studies.
Preparation of protein samples is straightforward for soluble monomeric proteins at concen‐
trations >1 mM. A wide range of deuterated buffers are available for controlling the pH of
the sample. Deuterated or an inorganic buffer are desirable to minimize interference within
1H spectra. The pH requires consideration as at pH > 8.0 labile amide 1H nuclei can rapidly
exchange with water becoming invisible. This can be utilized to reduce spectral complexity;
however, it may also affect residues of interest. Approximately one-third of human genes
code for membrane-associated proteins and to utilize NMR for studying the structure/func‐
tion relationship of these proteins requires the protein to be folded in a membrane environ‐
ment.[60] A range of membrane mimetics are available for solution and solid state NMR.[61]
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Scheme 2. The flowchart can be utilized as a general scheme for protein structural elucidation. Successful structural
elucidation for proteins relies on elaborate but well established 1H, 15N and 13C NMR experiments.
With the advent of 2D NMR experiments a strategy for the 3D structure determination of
small proteins utilizing homonuclear NMR spectra was established.[39] Extension of the 2D
NMR experiments to nD experiments along with isotopic labelling allowed for the 3D struc‐
ture determination of much larger proteins including membrane proteins.[12,62] 3D and 4D
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NMR techniques allow NMR data to be filtered by the 13C or 15N nuclei thus, reducing spec‐
tral overlap especially important for large proteins. In the past decade data on larger pro‐
teins has been facilitated with the development of Transverse Relaxation Optimized
SpectroscopY (TROSY) experiments.[63,64] NMR structural and dynamic analysis of a su‐
pra-molecular systems of 1 MDa has been achieved in combination with selective methyl la‐
belling.[65,66]
Typical NMR structure determination involves manual assignment of the backbone and
side-chain chemical shifts. Extensive assignment of the 1H-1H nOe from NOESY experiments
yields distance restraints as the volumes of the NOESY peaks are proportional to the aver‐
age of 1/r6 distance between the 1H nuclei. More recently routines for automatic resonance
and nOe assignments have been developed.[67,68] However, these methods require labelled
proteins and high-quality data to be effective. Regardless, protein structures are calculated
using a molecular dynamics computer simulation program with predefined a priori bond
connectivities, lengths and angles, and NMR derived restraints.
NMR restraints are most commonly from nOe experiments but may also include dihedral
angles, hydrogen bonding information and residual dipolar couplings.[69] Dihedral angles
can be calculated from measured/fitted[70] J-couplings or predicted from backbone chemical
shifts of the 1Hα, 13Cα, 13Cβ, 13CO and 15N resonances.[42,71] 1H nuclei exchange rates are re‐
duced in protein domains which are structured, or can be used to identify binding domains.
Residual dipolar couplings are valuable for identifying angular constraints for large do‐
mains and structural changes in substrate binding.[72,73]
An ensemble of lowest energy structures that satisfy the NMR derived restraints is calculat‐
ed. Quality of the calculated structures is based on the consistency of the experimental data
compared to the inputted restraints. Agreement of the structures among each other is evalu‐
ated with the RMSD to the lowest energy structure. In addition, NMR quality assessment
scores, recall, precision and F-measures (RPF scores) have been developed to directly meas‐
ure the quality of structures compared to the NOESY peak list.[74] Structural calculations
are an iterative process as not all restraints will be satisfied during the first simulated an‐
nealing calculation. It is typical for misassignments to occur due to spectral overlap or poor
volume calculations. In principle the number of correctly assigned and integrated restraints
should out-weigh the incorrectly assigned restraints. Thus during the calculations, a set of
restraints could be identified as being violated regularly. From the identification, the NMR
data is re-examined and the restraints corrected. Calculations are re-run and violations
checked iteratively until well defined structures with minimal restraint violations obtained.
Tertiary/quaternary structural aspects can be confirmed with NMR through diffusion ex‐
periments. NMR is one of the most accurate and precise methods for determining diffusion
constants.[13,75] Diffusion constants are related to the hydrodynamic radius through the
Stoke-Einstein equation and thus can be indirectly used to determine the mass of the diffus‐
ing species.[13,76] Of particular importance for proteins is determining the aggregation
number.[77]
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2.2. Pharmacophore identification & binding characterization
Natural products have a diverse range of mechanisms for eliciting a biological response.
Some natural products act as free-radical scavengers never directly interacting with the or‐
ganism, whereas other compounds bind to molecular targets triggering a signaling cascade
and altering the physiological state. Determining the mode of action of a small natural prod‐
uct molecule and where necessary the biological target requires extensive micro-biological
investigations. NMR can play a role within these investigations in particular by identifying
the pharmacophore of the natural product. The pharmacophore is the constituent of the
molecule that binds to a biological receptor to modify its biological response.[78] Identifying
the pharmacophore is an important aspect for drug discovery and understanding the mech‐
anism of action as it assists with “intelligent” design of drugs through modifications that
change binding characteristics (e.g. modifying the pharmacophore region) or solubility/
permeability properties (e.g. modifying sites distant from the pharmacophore).[79,80]
The difference in the NMR nOe response between a small molecule rapidly tumbling in sol‐
ution and a small molecule that is bound to a slowly tumbling large protein (see Section
2.1.1) is exploited to isolate and identify the pharmacophore (see chapter 14 of Ref. 81 and
Refs. 82,83). In order to clearly define the pharmacophore complete structural analysis of the
molecule is required (see Section 2.1.1); in order to sequence identify the active site within
the receptor, complete structural analysis of the protein (preferably including 15N and 13C
chemical shifts and connectivities) is required (see Section 2.1.2). A number of these techni‐
ques require mg quantities of purified ligand, receptor or both. Purifying compounds can be
a detrimental drawback especially if the receptor is a membrane bound protein that is diffi‐
cult to express and purify. Nevertheless, if the receptor is highly over-expressed within a
cell (e.g. cancer cell that over-expresses a particular protein) the possibility exists for the ex‐
periment to be performed in vivo.[84] Essentially 6 fundamental methods are available for
pharmacophore/binding characterization:[81,82] chemical-shift perturbations[85], saturation
transfer difference (STD)[86], water-logsy (wLogsy)[87,88], transfer-NOESY (tr-NOESY)[89],
selective relaxation[90] and diffusion editing[90]. Selective relaxation, diffusion editing and
tr-NOESY experiments in principle can be used for nM to mM binding constants (KD)
whereas chemical shift perturbations, STD and wLogsy are valuable for pM to mM KD rang‐
es with the concentration of receptor in the nM range. It is well beyond the scope of this
chapter to describe these experiments in detail especially since these experiments can be
combined to provide further characterization such as combining diffusion editing with STD
to simultaneously determine the pharmacophore and binding constant.[91] There are nu‐
merous reviews that provided explicit details (see Refs. 82,92-94).
With these tools both the ligand and receptor can be characterized. Typically chemical shift
perturbation or mapping methods helps to characterize the active site of the receptor. A ser‐
ies of 1H-15N or 1H-13C HSQC spectra of the labelled receptor are collected as the ligand is
titrated. Changes in chemical shifts of the receptor are indicative of 1H nuclei that are pertur‐
bed during binding, although care must be taken as to not over-interpret data as this could
also be indicative of structural alterations distant from the binding site. In cases where the
receptor is large (i.e. > 30 kDa) extensive resonance overlap may preclude unambiguous in‐
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terpretation of the HSQC data. Expression techniques to isolate particular amino acids or re‐
gions of the receptor are valuable for these experiments (see Section 2.1.2). One
disadvantage of this technique is the necessity of a complete resonance assignment of the
target or at least the active site.
Diffusion editing is a technique that can be used to determine the KD by examining the
change in diffusion properties of the ligand (typically < 2 kDa) upon titration to the receptor
(typically > 100 kDa). Although limited with pharmacophore and binding pocket identifica‐
tion, it is nevertheless a valuable tool to identify binding events from a mixture of possible
small ligands or to combine with other techniques.
The most often utilized techniques are the STD, wLogsy, tr-NOESY and selective relaxation.
[95] These techniques are used when the target is too large for chemical shift perturbations,
is not available with the desired isotopic labelling scheme or the target aggregates/precipi‐
tates at high concentrations. For these techniques, non-specific binding events in the nM-µM
range may be difficult to rule out unless compared with a known binder or used with a
competitive binder.[96] Regardless, these techniques are invaluable for specifically observ‐
ing resonances of a low-affinity ligands that bind to a receptor. With selective relaxation ex‐
periments, differences in relaxation properties of the ligand between a free and bound state
help identify interacting 1H nuclei that are in close proximity to the receptor. The relaxation
properties of the free ligand (i.e. no receptor) are compared to the relaxation properties for
the ligand at various receptor titers and mixing times. Changes within the relaxation values
can distinguish 1H nuclei that are in direct contact with the receptor from 1H nuclei that
show magnetization relay or 1H nuclei distant from the receptor. For wLogsy experiments,
1H resonances arising from 1H nuclei in close proximity to the receptor (i.e. are part of the
pharmacophore) are opposite sign to 1H resonances arising from 1H nuclei that are distant
from the receptor or are on a ligand that does not bind to the receptor (Fig. 1A). The wLogsy
also has the advantage of identifying 1H nuclei that are part of salt bridges between the li‐
gand and receptor. For STD experiments, small molecules that do not bind to the receptor
show a zero response (Fig. 1B) whereas the 1H nuclei of the pharmacophore show a re‐
sponse. Because the wLogsy is a direct observation technique whereas the STD is generated
from a difference of spectra, the wLogsy tends to have fewer artifacts and can be more sensi‐
tive. The tr-NOESY experiments can provide structural information about the ligand in the
bound state as well as potentially information on the type of amino acids on the receptor
involved in binding; typically no information regarding the sequence specificity of the ami‐
no acids is gleaned. The tr-NOESY is advantageous if the ligand changes conformation upon
binding as it can be utilized to determine the bound state structure of the ligand which is a
valuable asset for understanding the mode of action. The tr-NOESY is a 2D technique and as
such requires mg quantities of ligand and substantially more time to acquire the data. For
rapid screening of natural products the STD and wLogsy are the experiments of choice.
Beyond the individual experiments, combinations of these various experiments are possible.
For example, to investigate the folding/unfolding properties of a peptide the combination of
a 1H-15N HSQC and wLogsy can be used to monitor amide 1H nuclei exchange rates valua‐
ble for identifying H-bonding and buried residues.[77,97] This experimental combination
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can also be utilized with/without ligand to identify amide 1H nuclei that are involved with
ligand binding. Using the wLogsy to saturate the water signal avoids the challenges of the
typical methods of monitoring exchange by addition of D2O such as protein precipitation,
conformational changes induced by concentrating/diluting or complete loss of signal due to
rapid deuterium exchange.[77,98]
Figure 1. STD and wLogsy experiments can be utilized for identifying the pharmacophore of a small natural product
molecule. Panel A represents a wLogsy experiment (blue spectrum) of a compound that binds (positive peaks) to an
enzyme and a compound that does not bind (negative peaks). The positive peaks are of 1H nuclei that are adjacent or
in proximity to a salt bridge involving water. The negative peaks are from either the binding compound that are not
within the binding pocket, or from the control non-binder compound. The red spectrum is the reference spectrum.
Panel B represents the STD experiment (blue) of human serum albumin, a binder tryptophan and a non-binder su‐
crose. The positive peaks are from 1H nuclei on the tryptophan that are within the binding pocket. Peaks that are not
observed compared to the reference spectrum (red) represent either the control compound, or 1H nuclei on the tryp‐
tophan that are distant to the binding pocket.
2.3. Quantitative analysis & QA/QC
Nuclear MR technologies have traditionally been associated with molecular characteriza‐
tion. The quantitative nature has been acknowledged from integration of signals to distin‐
guish between for example methyl and methylene 1H nuclei; however, it has rarely been
exploited for absolute quantitative analysis (qNMR) or quality assurance/quality control
(QA/QC).[10] MR techniques are capable of accurately and precisely determining the con‐
centration of molecules within a purified sample or complex mixture without the need for
elaborate calibrations.[99] In addition samples can be in solution or semi-solid states.[100]
Relatively simple protocols have been developed that use a single certified external standard
to calibrate the instrument. From the calibrated system, other samples can be rapidly quanti‐
tated.[10,99]
MR technologies have the unique distinction of having a uniform molar response for all nu‐
clei of the same type, i.e., the NMR signals are proportional to the molar concentration of the
nuclei allowing for a direct comparison of the concentration of all compounds within a mix‐
ture. Thus for example, for all organic molecules regardless of the concentration, the intensi‐
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ty of each signal within the NMR spectrum is a direct measure of the number of 1H nuclei
that contribute to that signal. Furthermore, spectra can be recorded in such a manner as to
allow for accurate comparison between different samples within different sample tubes and
different solvents; the implications are far reaching for qNMR and QA/QC. For example,
concentrations of natural products or impurities can be determined for samples within
sealed tubes reducing the handling requirements of toxic or precious samples, or rapid
crude or refined product profiling ensuring purity, integrity and consistency with applica‐
tions to fractionation or end-product QA/QC.[99] Fully automated protocols have been de‐
veloped that have been coupled with metabolomics investigations providing absolute
scaling for temporal data.
2.4. Metabolomics analysis
Analysis of metabolites and metabolic flux can help ascertain the effects of a particular natu‐
ral product or extract on an organism. Metabolic analysis can be utilized while identifying
biological activity in vitro, or during in vivo investigations. Perhaps one of the best practical
definitions of metabolomics was offered by Oliver describing it as an approach for simulta‐
neously measuring the complete set of metabolites (low molecular weight intermediates)
that are context dependent and which vary according to the physiological, developmental or
pathological state of an organism.[101] From the perspective of natural products, such a def‐
inition fits in the framework of extracts from plants, fungi and secretions from microorgan‐
isms such as bacteria. When metabolomics is viewed from context dependence, only those
metabolites that vary according to environmental, biochemical, and/or physiological fluctua‐
tions are important. In this regard, there are a vast number of metabolites present in botani‐
cal extracts and secretions from organisms that are useful for inducing biological responses
in organisms including humans. For instance, ginseng has been argued to induce biochemi‐
cal changes in humans that lead to anti-tumor, antioxidant, anti-fatigue and anti-stress activ‐
ities while Streptomyces coelicolor secrete therapeutic natural products during their quiescent
growth phase.[102,103] The discussion within this section follows the aforementioned defi‐
nition and is restricted to metabolomics applied to botanical natural products since it is one
of the fastest growing subsections established as “plant metabolomics.”[104-106] NMR is a
suitable method for such analyses since it allows simultaneous detection of a diverse group
of both primary metabolites (sugars, organic acids, amino acids etc.) and secondary ones
(flavonoids, alkaloids tri-terpenes etc.) Nevertheless, the applications are extensible to the
“animal kingdom” metabolomics since the underlying sample composition is similar and
characterized by large heterogeneity exhibiting vast dynamic range in concentration.
The numerous advantages of NMR have been a major driver for developing NMR based
metabolomics technologies. NMR is ideal for resolving the complexity of metabolomics sam‐
ples given that methods exist for compounds with nuclei such as 1H, 13C, 15N and 31P to pro‐
vide spectral fingerprints with compound specificity and quantitative accuracy even within
complex matrices. For example, from the un-annotated 1D 1H NMR spectra of seaweed ex‐
tracts, visible differences in chemical composition are observed (Fig. 2). NMR signals have a
uniform molar response (see Section 2.3). This property has particularly been important
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with propelling NMR metabolomics as a technology. NMR is a non-destructive technique
ideal suited because many of these samples are difficult to obtain and may be precious. The
stability of many NMR instrumentation allows for repeated measures (often years apart) of
a sample with accurate reproducibly. This advantage also lends the technology to inter-labo‐
ratory studies that are important for establishing the robustness of a given measurement
and technique.[52] Advances in technology now allow for high throughput analysis with
automated, temperature controlled sample changers such as Bruker’s SampleJet®.
Figure 2. NMR spectra of aqueous extracts from various strains of brown seaweeds showing distinct differences with‐
in the spectral features.
The most commonly cited disadvantage of NMR for metabolomics is the lack of sensitivity.
[106] This is a major hindrance given that in typical sample matrices, the concentration of
constituent metabolites often exhibits a large dynamic range in concentration. Low abun‐
dance metabolites will invariantly be overlapped by highly abundant ones. Furthermore, in
some applications such low level metabolites maybe of high value. For instance a phyto‐
chemical preparation may exhibit activity in a biological readout but such activity is in‐
duced by the low level metabolites which are undetectable via NMR. Approaches for
simplifying sample matrices have been developed in order to separate, for instance, lipo‐
philic from hydrophilic metabolites.[107] In addition, recent advances in NMR hardware
have significantly improved sensitivity, especially with the advent of cryogenic probes and
microprobes.
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NMR-based metabolomics applications have been in the literature for over two decades,
[108,109] but the technology only realized widespread acceptance and application in the lat‐
er part of the last decade.[105,110-112] This shift is attributed to the utility of pattern recog‐
nition methods for analysis of multiple spectra, allowing the visualization of patterns
corresponding to differences among samples and identification of chemical shifts responsi‐
ble for eliciting such differences.[113] Specifically, principal component analysis (PCA) has
been a significant driver as it allows patterns associated with the variability in the relative
concentrations of metabolites to be assessed by the human eye, often in two dimensions.
PCA analysis assisted with the classification of different extracts of the sea weed Ascophyl‐
lum nodosum (Fig. 3).[114] In recent years, many other pattern recognition methods (classi‐
fied either as supervised or unsupervised) have been developed and applied to data.
Unsupervised methods do not include a priori knowledge of the class memberships of a giv‐
en sample. Such methods include PCA, SIMCA, independent component analysis (ICA) and
the so called machine learning methods such as neural networks and self organizing maps
(SOM). On the other hand, supervised methods use information about the samples in order
to build models that can later be used to predict the class to which an unknown sample be‐
longs. Such methods include partial least squares discriminant analysis (PLS-DA).
Figure 3. A principal component scores plot of a product characterization study showing similar samples from one
manufacturer tightly clustered in the center (solid red squares); the ellipse encloses these samples plus two others that
are known to incorporate that manufacturer’s samples (solid blue squares and circle). Competitors’ samples are dis‐
tributed throughout the plot with each symbol representing products from a single manufacturer. Unfilled symbols
represent samples recorded under acidic conditions.
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Ultimately,  the impetus for  natural  product  metabolomics  analyses  is  the need for  high
throughput screening to determine biological activity and the requirements from the nu‐
traceutical industry to purport therapeutic health benefits from unprocessed foods. Tradi‐
tional approaches with the development of novel drugs are difficult, expensive and time
consuming. It is estimated that over $800 million and an average of 14.2 years are spent
before a novel drug application is approved. Because natural products are a rich source
of lead compounds in the drug discovery pipeline, the metabolomics approach provides
an avenue for  a  systematic  characterization of  complex mixtures  such as  phytochemical
extracts  linking  observations  made  via  biological  assays  without  the  need  for  isolation.
This  promises  to  complement  high  throughput  screening  of  compounds  in  order  to
shorten the drug discovery process.  Indirectly,  NMR has been used in metabolomics  to
measure the fate  of  consumed natural  products  and their  effects  on human physiology.
One study has shown that the consumption of dark chocolate, for instance, affects ener‐
gy homeostasis in humans.[115] In another study, differences in metabolic profiles were
observed in human urine following consumption of black compared to green tea specifi‐
cally  increases  in  urinary  hippuric  acid  and 1,3-dihydroxyphenyl-2-O-sulfate,  which  are
end products  of  tea flavonoid degradation.[116]  Several  other studies exist  in the litera‐
ture and have been reviewed for instance within Ref. 117.
Perhaps one of the biggest gaps with metabolomics developments for natural products is
the lack of certified reference materials for quantification of analytes. Such reference materi‐
als would enhance product characterization and validation of biological observations, espe‐
cially with studies of bioactivity assessment. Those studies are often inconsistent due to
inadequate chemical characterization of complex botanical mixtures, making comparison of
results across studies difficult. Fortunately, it is possible to determine the concentration of
‘active’ compounds using external standards, via NMR, as long as both the external stand‐
ard and the compound of interest are of the same nuclei type (see Section 2.3).[10]
2.5. Semi-solid state & macromolecular assemblies
In addition to studying soluble molecules or extracts dissolved in solution state, it can be
advantageous and/or necessary to study semi-solids such as intact tissues, cells, raw ma‐
terials  or  product  formulations;  metabolites  or  components  are  in  their  native  environ‐
ment  i.e.  potentially  time  consuming  and  disrupting/degrading  extractions,  or  chemical
modifications are not required in order to obtain valuable information. Semi-solid materi‐
als require specialized NMR probes to overcome sever spectral line-broadening as result
of the restricted molecular mobility. To acquire a high-resolution spectrum of a semi-sol‐
id,  High Resolution Magic  Angle  Spinning (HR-MAS) was developed in  the  late  1990’s
as a  hybrid between solid and solution state NMR.[118]  Similar  to solid state NMR the
spinning of the sample at the “magic angle” (54.7°) to the applied magnetic field reduces
line  broadening effects.  Spinning speeds are  typically  between 3  to  5  kHz and cells  re‐
main intact and viable.[119] HR-MAS requires <100 uL of the semi-solid.  HR-MAS does
not require the high powered pulses that solid state NMR requires and many of the nD
experiments  that  are  utilized for  structural  biology can be  applied,  although stable  iso‐
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tope labelling is preferred for the less abundant 13C, and 15N nuclei. HR-MAS can be ap‐
plied  for  many  natural  product  studies[118,120]  commonly  used  to  study  metabolic
changes in diseased and treated tissues,[121,122] metabolism,[123]  combinatorial  chemis‐
try[124] and whole cells[125]. Intensities in the HR-MAS NMR spectra are dependent on
the  environment  of  the  analyte  and  as  such  molecules  that  are  in  rigid  environments
with completely restricted mobility are not detected. Macro molecular assemblies on-the-
other-hand can be examined for profiling and quantitation of algae lipid content and pol‐
ysaccharides or metabolites.[100]
3. MRI
MRI is a nuclear MR technique applicable for natural product development in particular
during in vivo testing and diagnostic stages. MRI is capable of producing 3D images that
can be used to monitor changes in brain activity in response to application of a natural
product via  fMRI techniques[126-128],  indirectly monitor the effects of a natural product
on tumours[129], or directly monitor the bio-distribution and bio-accumulation of a natu‐
ral product by tagging the compound with an MRI contrast agent.[130-133].
Direct monitoring of the natural product is one of the most typical methods for drug de‐
velopment.  For direct  monitoring however,  the molecules should be tagged with a MRI
contrast agent which contains a paramagnetic centre causing 1H nuclei on water in close
proximity  to  “relax”  much  faster  than  1H  nuclei  distant  from  the  paramagnetic  centre.
[134] This rapid relaxation is exploited with MRI and is depicted as “dark spots” within
the image whereas unaffected water molecules remain as bright areas.  In order to “tag”
a  natural  product  with  a  MRI  contrast  agent  such  as  super-paramagnetic  iron  oxide
(SPIO), the complete structure and pharmacophore identification is valuable (see Section
2.2)  as  it  allows one to  pick a  functional  group distant  from the active site  that  can be
chemically  coupled  to  the  contrast  agent.  Many  SPIO  contrast  agents  are  commercially
available with a variety of functional groups amenable to chemical coupling under aque‐
ous conditions.[134]
Once the natural  product  is  conjugated to the paramagnetic  particle,  it  can be adminis‐
tered to an organism and imaged. The bio-distribution and bio-accumulation of the tag‐
ged molecule is monitored and compared against a control particle that does not contain
the active natural product.[133,135-137] The difference in clearance time is considered as
conformation that  the molecule is  associated with the tissue being examined.  As an ex‐
ample the peptide SOR-C27,  a  27  amino acid fragment  of  the  paralytic  natural  product
peptide  SOR-54  from  the  Northern  Short  Tail  shrew  (Blarina  brevicauda)  was  found  to
bind the calcium ion channel  TRPV6 which is  highly over-expressed by breast,  prostate
and ovarian  cancers.[138,139]  The  SOR-C27 peptide  was  chemically  bonded to  a  malei‐
mide functionalized SPIO particle through the sulfur centre of the Cys-14 residue. From
MRI investigations on an ovarian cancer xenograft mouse model, the SPIO-peptide parti‐
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cle persisted at the tumour site 24 hours post injection whereas the control SPIO particle
rapidly cleared. The persistence of the SPIO-peptide particle at the tumour site is confor‐
mation that the peptide is associated with the tumour[139].
4. Summary
A  comprehensive  overview  of  MR  techniques  for  natural  product  development  is  well
beyond the scope of  a  single  chapter  or  book.  The fundamental  experiments  have been
briefly  outlined  and  the  typical  information  that  is  gleaned  from  the  experiments  pre‐
sented. Many other opportunities were not covered such as determining equilibrium dis‐
sociating  constants,  or  use  of  spin  labels  for  lead  drug  optimization.  MRI  has
tremendous application for later stage in vivo applications of the drug development pipe‐
line. Together the MR technologies of NMR and MRI can cover the full range of natural
product drug development from discovery through to clinical testing (Fig. 4).
Figure 4. Applications for nuclear MR technologies cover the entire range of natural product development from fun‐
damental molecular sciences through to practical health care. Spectroscopic applications (red) are delineated from
imaging applications (blue).
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